Production (Stage)
BioStem Technologies, Inc.
BSEM
$11.98
-$0.0225-0.19%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 73.08% | 2,258.90% | 6,872.30% | 6,872.30% | 7,173.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 73.08% | 2,258.90% | 6,872.30% | 6,872.30% | 7,173.77% |
| Cost of Revenue | -61.64% | 1,203.81% | 1,718.49% | 1,718.49% | 2,100.49% |
| Gross Profit | 80.63% | 2,366.94% | 8,104.12% | 8,104.12% | 8,253.58% |
| SG&A Expenses | 85.07% | 1,751.83% | 1,686.82% | 1,686.82% | 800.79% |
| Depreciation & Amortization | 4.05% | 1.43% | -9.83% | -9.83% | -10.98% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 80.39% | 1,679.56% | 1,636.55% | 1,636.55% | 823.33% |
| Operating Income | 13.91% | 1,605.56% | 425.02% | 425.02% | 233.06% |
| Income Before Tax | 18.86% | 695.05% | 403.90% | 403.90% | 224.09% |
| Income Tax Expenses | -32.69% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 37.61% | 543.40% | 322.85% | 322.85% | 191.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.61% | 543.40% | 322.85% | 322.85% | 191.00% |
| EBIT | 13.91% | 1,605.56% | 425.02% | 425.02% | 233.06% |
| EBITDA | 13.80% | 1,746.36% | 434.39% | 434.39% | 236.83% |
| EPS Basic | 34.65% | 466.49% | 281.33% | 281.33% | 170.09% |
| Normalized Basic EPS | 16.27% | 1,024.54% | 347.18% | 347.18% | 195.56% |
| EPS Diluted | 0.00% | 380.70% | 236.36% | 236.36% | 159.67% |
| Normalized Diluted EPS | -12.53% | 814.25% | 288.71% | 288.71% | 180.69% |
| Average Basic Shares Outstanding | 2.19% | 20.94% | 22.91% | 22.91% | 29.85% |
| Average Diluted Shares Outstanding | 35.87% | 56.54% | 61.03% | 61.03% | 53.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |